Vaxart, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8M | $9.3M | $24.6M | $68.7M | $33.6M | $20.4M | $14.8M | $35.0M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $12.4M | $26.3M | $19.8M | $17.5M | $19.9M | $24.1M | $17.8M | $26.1M |
| SG&A Expense | $3.5M | $8.0M | $9.4M | $10.2M | $18.0M | $9.4M | $5.4M | $6.2M |
| Operating Income | $-10.0M | $-25.2M | $-19.5M | $-11.5M | $-22.1M | $-22.9M | $-9.8M | $-1.2M |
| Operating Margin | -171.5% | -271.0% | -79.3% | -16.7% | -65.8% | -112.3% | -65.8% | -3.4% |
| Interest Expense | $3.0M | — | — | — | — | — | — | $210.0K |
| Pretax Income | $-9.6M | $-25.4M | $-19.2M | $-11.3M | $-8.8M | $-19.7M | $-9.5M | $-887.0K |
| Income Tax Expense | $300.0K | — | $-100.0K | $-300.0K | $100.0K | $-500.0K | $-2.0M | $-1.8M |
| Net Income | $-9.6M | $-25.4M | $-19.1M | $-11.0M | $-8.9M | $-19.2M | $-4.5M | $878.0K |
| Net Margin | -164.1% | -273.1% | -77.6% | -16.0% | -26.5% | -94.1% | -30.5% | 2.5% |
| EPS (Basic) | $-91.65 | $-0.66 | $-0.54 | $-0.35 | $-0.32 | $-0.85 | $-0.18 | $0.02 |
| EPS (Diluted) | $-91.65 | $-0.66 | $-0.54 | $-0.35 | $-0.32 | $-0.85 | $-0.18 | $0.02 |
| Shares Outstanding (Basic) | 38.6M | 38.6M | 35.4M | 31.3M | 28.2M | 22.7M | 42.3M | 44.3M |
| Shares Outstanding (Diluted) | 38.6M | 38.6M | 35.4M | 31.3M | 28.2M | 22.7M | 42.3M | 44.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |